FRESH TRACKS THERAPEUTICS IN (FRTX)

US10802T2042 - Common Stock

0.79  -0.02 (-2.48%)

After market: 0.77 -0.02 (-2.53%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
10.05M6.94M400.00K1.82M7.92M
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
19.36M28.48M40.65M22.80M27.59M
Research and Development
5.79M14.04M28.23M11.22M20.21M
Selling, General, and Administrative Expenses
13.58M14.43M12.42M11.58M7.37M
Operating Income
-9.29M-21.53M-40.24M-20.98M-19.67M
Interest Income/Expense
70.00K430.00K370.00K60.00K-1.72M
Other Income/Expense
N/AN/AN/AN/A-10.00K
Non Recurring Items
N/AN/A400.00K0.00-2.48M
Income Before Taxes
-8.99M-21.10M-39.47M-20.91M-23.88M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-8.99M-21.10M-39.47M-20.91M-13.60M
EBITDA
-9.25M-21.50M-40.22M-20.97M-19.64M
 
Per Share Data
EPS Diluted Total Ops
-2.67-7.51-22.17-38.72-194.28
Non GAAP EPS
N/AN/A-23.85N/AN/A
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
-89.45%-304.03%-9867.50%-1148.90%-171.72%
Operating Profit Margin
-92.44%-310.23%-10060.00%-1152.75%-248.36%

All data in USD

Charts